title: Is 'chemo-fog'/'chemo-brain' caused by cancer chemotherapy?
authors.affiliation: Temple University School of Pharmacy, Philadelphia, PA 19140, USA. robert.raffa@temple.edu
authors.forename: R B
authors.initials: RB
authors.lastname: Raffa
authors.forename: P V
authors.initials: PV
authors.lastname: Duong
authors.forename: J
authors.initials: J
authors.lastname: Finney
authors.forename: D A
authors.initials: DA
authors.lastname: Garber
authors.forename: L M
authors.initials: LM
authors.lastname: Lam
authors.forename: S S
authors.initials: SS
authors.lastname: Mathew
authors.forename: N N
authors.initials: NN
authors.lastname: Patel
authors.forename: K C
authors.initials: KC
authors.lastname: Plaskett
authors.forename: M
authors.initials: M
authors.lastname: Shah
authors.forename: H-F
authors.initials: HF
authors.lastname: Jen Weng
mesh_terms: D000368:Aged; D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects*; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D003072:Cognition Disorders / Q000139:chemically induced* / Q000145:classification / Q000175:diagnosis; D006801:Humans; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D009483:Neuropsychological Tests; D016032:Randomized Controlled Trials as Topic
chemical_list: D000970:Antineoplastic Agents